NCT00302380
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
Clinical trial condition
Attention Deficit Hyperactivity Disorder
Explore clinical trials studying Attention Deficit Hyperactivity Disorder. Study availability and eligibility vary by location and protocol.
453 public trials
34 recruiting studies
Attention Deficit Hyperactivity Disorder trial results
Completed
Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD
NCT00556296
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
NCT00269815
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
NCT00269789
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
NCT00269802
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
NCT00280228
- Conditions
- Alcohol Drinking, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +10 more
- Locations
-
- Youth and Family Research Program Pittsburgh, Pennsylvania, United States
NCT00866996
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
NCT00326300
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified
NCT00409708
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +5 more
- Locations
-
- Novartis Pharmaceuticals Investigational site Houston, Texas, United States
NCT00304681
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
- Locations
-
Not specified